Rolida, Ramel D.

HRN: 04-18-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2025
CO-AMOXICLAV 625MG (TAB)
09/11/2025
09/17/2025
PO
625
TID
CEllulitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines